Table 1.
Genotype | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
IDU-A | CRF02_AG | Other genotypesa | ||||||||
Region | IDUs | Hetero | Other | IDUs | Hetero | Other | IDUs | Hetero | Other | Total number |
East Kazakhstan | 13 | 4 | 0 | 2 | 1 | 0 | 3 | 0 | 0 | 23 |
Almaty | 1 | 4 | 2 | 25 | 31 | 2 | 1 | 4 | 0 | 70 |
Pavlodar | 5 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
Karaganda | 27 | 35 | 2 | 1 | 2 | 0 | 0 | 1 | 0 | 68 |
South Kazakhstan | 4 | 11 | 0 | 0 | 5 | 0 | 0 | 1 | 0 | 21 |
Other regions | 4 | 3 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 11 |
Total | 54 | 63 | 6 | 28 | 41 | 3 | 4 | 6 | 0 | 205 |
Subtype B, CRF03_AB, CRF63_02A1, and CRF07_BC recombinants.
IDU, intravenous drug user; Hetero, heterosexual.